We are live on
!
Find out more
PCA
Personal Capital Advisors Portfolio holdings
AUM
$20.6B
1-Year Est. Return
13.65%
This Fund
S&P 500
This Quarter
Est. Return
-6.2%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
–
AUM
$18.5B
AUM Growth
-$589M
(-3.1%)
Cap. Flow
+$804M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
42.74%
Holding
476
New
33
Increased
302
Reduced
83
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$132M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$54.8M |
| 3 |
Edwards Lifesciences
EW
|
+$51.6M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$51.3M |
| 5 |
Fortinet
FTNT
|
+$51.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$147M |
| 2 |
Encompass Health
EHC
|
+$43.8M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$28.2M |
| 4 |
Under Armour Class C
UA
|
+$22.1M |
| 5 |
UnitedHealth
UNH
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.15% |
| 2 | Consumer Staples | 4.49% |
| 3 | Utilities | 4.26% |
| 4 | Healthcare | 3.85% |
| 5 | Financials | 3.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cardlytics
CDLX
$21.7M
| $370K | ﹤0.01% |
3,940
| – | – |
|
|
NVO
327
Novo Nordisk
NVO
$208B
| $363K | ﹤0.01% |
7,288
+502
| +7% | +$26.9K |
|
328
Stryker
SYK
$125B
| $357K | ﹤0.01% |
1,765
+157
| +10% | +$33K |
|
329
iShares US Technology ETF
IYW
$23.6B
| $354K | ﹤0.01% |
4,827
+1,752
| +57% | +$149K |
|
330
Paycom
PAYC
$7.64B
| $354K | ﹤0.01% |
1,073
+6
| +0.6% | +$2.07K |
|
331
Humana
HUM
$43.7B
| $350K | ﹤0.01% |
721
+228
| +46% | +$111K |
|
332
EOG Resources
EOG
$79.2B
| $345K | ﹤0.01% |
3,090
+730
| +31% | +$81.9K |
|
333
NetApp
NTAP
$35B
| $343K | ﹤0.01% |
5,546
| – | – |
|
334
Blackrock
BLK
$169B
| $338K | ﹤0.01% |
615
+239
| +64% | +$156K |
|
335
Capital One
COF
$128B
| $338K | ﹤0.01% |
3,669
+493
| +16% | +$52.5K |
|
336
iShares Biotechnology ETF
IBB
$9.21B
| $336K | ﹤0.01% |
2,877
+88
| +3% | +$10.9K |
|
337
iShares Russell Mid-Cap ETF
IWR
$56B
| $336K | ﹤0.01% |
5,399
+761
| +16% | +$52.3K |
|
338
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $336K | ﹤0.01% |
10,262
-44
| -0.4% | -$1.61K |
|
339
Halozyme
HALO
$9.79B
| $332K | ﹤0.01% |
8,404
| – | – |
|
340
Intuitive Surgical
ISRG
$127B
| $331K | ﹤0.01% |
1,767
+223
| +14% | +$47.9K |
|
341
iShares MSCI USA Momentum Factor ETF
MTUM
$25.4B
| $330K | ﹤0.01% |
2,515
+693
| +38% | +$97.2K |
|
342
Electronic Arts
EA
$53B
| $328K | ﹤0.01% |
2,836
+26
| +0.9% | +$3.29K |
|
343
Phillips 66
PSX
$84.9B
| $327K | ﹤0.01% |
+4,048
| New | +$345K |
|
344
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $326K | ﹤0.01% |
8,149
| – | – |
|
345
Halliburton
HAL
$26.9B
| $325K | ﹤0.01% |
13,210
+1,289
| +11% | +$36.9K |
|
346
Agilent Technologies
A
$39.1B
| $323K | ﹤0.01% |
2,660
+457
| +21% | +$58.7K |
|
347
Globant
GLOB
$1.58B
| $321K | ﹤0.01% |
+1,717
| New | +$354K |
|
348
TSMC
TSM
$2.1T
| $319K | ﹤0.01% |
4,655
+723
| +18% | +$59.8K |
|
|
FISV
349
Fiserv Inc
FISV
$28.8B
| $318K | ﹤0.01% |
3,400
+566
| +20% | +$57.7K |
|
350
State Street SPDR S&P Biotech ETF
XBI
$9.6B
| $318K | ﹤0.01% |
4,012
+276
| +7% | +$23.3K |
|
Similar funds
PG
RCAMU
GG
AIM
AAM
ZCA
GJIC
SBL
Personal Capital Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Personal Capital Advisors held 476 positions worth $18.5B, down 3.1% from $19.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Personal Capital Advisors deployed $804M of net new capital in Q3 2022, opening 33 new positions and adding to 302 existing holdings. Its largest new stake was Edwards Lifesciences: 536,233 shares worth $44.3M.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.8% a quarter earlier, followed by Consumer Staples and Utilities.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $147M trimmed.
- Personal Capital Advisors's largest Q3 2022 buy was Edwards Lifesciences: 536,233 shares worth $44.3M.
- Personal Capital Advisors added most to Schwab International Equity ETF in Q3 2022, an estimated $132M increase.
- Personal Capital Advisors's biggest Q3 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $147M.
- Personal Capital Advisors fully exited InterDigital in Q3 2022, selling an estimated $11.1M.
- Personal Capital Advisors's ten largest holdings make up 43% of its $18.5B portfolio in Q3 2022.
- Personal Capital Advisors opened 33 new positions and closed 23 in Q3 2022.
- Personal Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $18.5B.
Based on Personal Capital Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.